Name:
Professor Luke O'Neill
Organisation:
Trinity College Dublin
Year elected:
2024
Primary professional setting:
Academia
Luke O’Neill is Professor of Biochemistry in the School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute at Trinity College Dublin, Ireland. He is a world expert on innate immunity and inflammation. His main research interests include Toll-like receptors, Inflammasomes and Immunometabolism. He is listed by Thompson Reuters/ Clarivates in the top 1% of immunologists in the world, based on citations per paper. Professor O'Neill is co-founder of Sitryx, which aims to develop new medicines for inflammatory diseases. Another company he co-founded, Inflazome was recently acquired by Roche.He was awarded the Royal Dublin Society / Irish Times Boyle Medal for scientific excellence, the Royal Irish Academy Gold Medal for Life Sciences, The Society for Leukocyte Biology (SLB) Dolph O. Adams award, the European Federation of Immunology Societies Medal, the Milstein Award of the International Cytokine and Interferon Society and the Landsteiner Award from the Austrian Academy of Sciences. He is a member of the Royal Irish Academy, EMBO (European Molecular Biology Organisation) and a Fellow of the Royal Society. Luke also has a passion for communicating science to the public. He has a weekly radio slot on the Pat Kenny show on Newstalk and has published several popular science books, most notably ‘Never Mind the B#ll*cks Here’s the Science’ which won the 2020 Irish non-fiction book of the year, ‘Keep Calm and Trust the Science – an extraordinary year in the life of an immunologist’ which was his diary during the COVID19 pandemic and with Penguin/Random House ‘To Boldly Go where No Book has Gone Before’.